Ameritas Investment Partners’s Compass Therapeutics CMPX Stock Holding History

Ameritas Investment Partners’s Portfolio CMPX Stock Details CMPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$56.2K	Hold	10,621	–	–	﹤0.01%	2032
2025 Q4	$57K	Buy	10,621 +3,085	+41%	+$14.2K	﹤0.01%	2032
2025 Q3	$26.4K	Hold	7,536	–	–	﹤0.01%	2541
2025 Q2	$19.6K	Hold	7,536	–	–	﹤0.01%	2667
2025 Q1	$14.3K	Hold	7,536	–	–	﹤0.01%	2683
2024 Q4	$10.9K	Hold	7,536	–	–	﹤0.01%	2879
2024 Q3	$13.9K	Hold	7,536	–	–	﹤0.01%	2816
2024 Q2	$7.54K	Hold	7,536	–	–	﹤0.01%	2991
2024 Q1	$14.9K	Hold	7,536	–	–	﹤0.01%	2677
2023 Q4	$11.8K	Hold	7,536	–	–	﹤0.01%	2792
2023 Q3	$14.8K	Hold	7,536	–	–	﹤0.01%	2664
2023 Q2	$24K	Buy	+7,536	New	+$23.7K	﹤0.01%	2471

Other funds holding CMPX

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM